Application
19612059 · ANTIBODY-DRUG CONJUGATE CONTAINING HETEROCYCLIC COMPOUND HAVING MUTANT KRAS PROTEIN DEGRADATION-INDUCING EFFECT
Filed 2026-08-04 · Pending The official file ↗ · Art unit · Astellas Pharma Inc. · FOLEY & LARDNER LLP
Office actions
0
first was
RCEs
0
no appeal
To first action
n/a
to disposition n/a
Statutes raised
·
0 actions read